: Following momentum from 2012, it nearly quadrupled in 2013, gaining 298% .
: A medical device maker that saw a breakout after cost-cutting and management shifts, rising 110% in 2013. underperforming stocks to buy 2013
: Targeted for 27% upside following its acquisition of rival Cooper Industries. Undervalued Dividend & Large-Cap Stocks : Following momentum from 2012, it nearly quadrupled
In 2013, the investment landscape for underperforming or "undervalued" stocks was dominated by a search for "turnaround stories"—companies that had been battered in 2012 but showed signs of fundamental recovery. High-Potential "Turnaround" Picks : Following momentum from 2012
: Noted for a record $5.39 billion in Q1 revenue with a projected 24.8% upside.
: Previously struggling, this pharmacy chain's stock recovered significantly, moving back above the $5.00 mark. Goldman Sachs "Most Undervalued" Selections (May 2013)